Harrow

HROWNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.507 B

$40.44 +1.30%

Close of 7 Aug 2026

Revenue

$272.3M

#2183 by revenue

Earnings

-$5.14M

Loss-making

Shares outstanding

37,229,705

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#136Forte BiosciencesFBRX$1.57B
#137XencorXNCR$1.55B
#138HarrowHROW$1.51B
#139Avalyn PharmaAVLN$1.50B
#140InnovivaINVA$1.48B

Where these numbers come from

Share counts and financials for Harrow are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.